Spechler, Philip A. http://orcid.org/0000-0003-3833-7672
Chaarani, Bader
Orr, Catherine
Albaugh, Matthew D.
Fontaine, Nicholas R.
Higgins, Stephen T.
Banaschewski, Tobias
Bokde, Arun L. W.
Quinlan, Erin Burke
Desrivières, Sylvane
Flor, Herta
Grigis, Antoine
Gowland, Penny
Heinz, Andreas
Ittermann, Bernd
Artiges, Eric
Martinot, Marie-Laure Paillère
Nees, Frauke
Orfanos, Dimitri Papadopoulos
Paus, Tomáš
Poustka, Luise
Hohmann, Sarah
Fröhner, Juliane H.
Smolka, Michael N.
Walter, Henrik
Whelan, Robert
Schumann, Gunter
Garavan, Hugh
Funding for this research was provided by:
European Union (LSHM-CT- 2007-037286)
National Institutes of Health (U54 EB020403)
National Institute of General Medical Sciences (P20GM103644)
Article History
Received: 11 March 2020
Accepted: 27 July 2020
First Online: 8 August 2020
Compliance with ethical standards
:
: Dr. Banaschewski served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire. He received conference support or speaker’s fee by Lilly, Medice, Novartis and Shire. He has been involved in clinical trials conducted by Shire and Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.
: The IMAGEN study conformed to the ethical standards outlined by Declaration of Helsinki and was approved by ethics committees at each site.
: After description of the IMAGEN study to the participants and their parents, written informed consent was obtained.